2346 related articles for article (PubMed ID: 17331172)
21. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.
Furuya CK; de Oliveira CP; de Mello ES; Faintuch J; Raskovski A; Matsuda M; Vezozzo DC; Halpern A; Garrido AB; Alves VA; Carrilho FJ
J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042
[TBL] [Abstract][Full Text] [Related]
22. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
Wong VW; Wong GL; Choi PC; Chan AW; Li MK; Chan HY; Chim AM; Yu J; Sung JJ; Chan HL
Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244
[TBL] [Abstract][Full Text] [Related]
23. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
[TBL] [Abstract][Full Text] [Related]
24. Clinical and pathological differences between alcoholic hepatitis and non-alcoholic steatohepatitis.
Sugimoto M; Sadamoto T; Nonaka H
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Feb; 38(1):34-45. PubMed ID: 12687723
[TBL] [Abstract][Full Text] [Related]
25. Predictive factors for nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD).
Fierbinteanu-Braticevici C; Baicus C; Tribus L; Papacocea R
J Gastrointestin Liver Dis; 2011 Jun; 20(2):153-9. PubMed ID: 21725512
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis.
Shimada M; Kawahara H; Ozaki K; Fukura M; Yano H; Tsuchishima M; Tsutsumi M; Takase S
Am J Gastroenterol; 2007 Sep; 102(9):1931-8. PubMed ID: 17511754
[TBL] [Abstract][Full Text] [Related]
27. Nonalcoholic fatty liver disease in severely obese subjects.
Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
[TBL] [Abstract][Full Text] [Related]
28. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease].
Kim KO; Park SH; Park CH; Han TH; Yoo KS; Kim JH; Lee MS; Kim DJ; Park CK; Cho HD
Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885
[TBL] [Abstract][Full Text] [Related]
29. Microvesicular fat, inter cellular adhesion molecule-1 and regulatory T-lymphocytes are of importance for the inflammatory process in livers with non-alcoholic steatohepatitis.
Söderberg C; Marmur J; Eckes K; Glaumann H; Sällberg M; Frelin L; Rosenberg P; Stål P; Hultcrantz R
APMIS; 2011 Jul; 119(7):412-20. PubMed ID: 21635548
[TBL] [Abstract][Full Text] [Related]
30. Predictors of nonalcoholic steatohepatitis in patients with elevated alanine aminotransferase activity.
Puljiz Z; Stimac D; Kovac D; Puljiz M; Bratanić A; Kovacić V; Kardum D; Bonacin D; Hozo I
Coll Antropol; 2010 Mar; 34 Suppl 1():33-7. PubMed ID: 20402293
[TBL] [Abstract][Full Text] [Related]
31. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
Krawczyk K; Szczesniak P; Kumor A; Jasinska A; Omulecka A; Pietruczuk M; Orszulak-Michalak D; Sporny S; Malecka-Panas E
J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
[TBL] [Abstract][Full Text] [Related]
32. Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis.
Mishra P; Nugent C; Afendy A; Bai C; Bhatia P; Afendy M; Fang Y; Elariny H; Goodman Z; Younossi ZM
Liver Int; 2008 Sep; 28(8):1080-6. PubMed ID: 18647236
[TBL] [Abstract][Full Text] [Related]
33. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.
Haukeland JW; Konopski Z; Linnestad P; Azimy S; Marit Løberg E; Haaland T; Birkeland K; Bjøro K
Scand J Gastroenterol; 2005 Dec; 40(12):1469-77. PubMed ID: 16293559
[TBL] [Abstract][Full Text] [Related]
34. Predicting fibrosis worsening in obese patients with NASH through parenchymal fibronectin, HOMA-IR, and hypertension.
Sorrentino P; Terracciano L; D'Angelo S; Ferbo U; Bracigliano A; Vecchione R
Am J Gastroenterol; 2010 Feb; 105(2):336-44. PubMed ID: 19861959
[TBL] [Abstract][Full Text] [Related]
35. Serum leptin levels in patients with nonalcoholic chronic liver disease.
Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
[TBL] [Abstract][Full Text] [Related]
36. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
Savvidou S; Hytiroglou P; Orfanou-Koumerkeridou H; Panderis A; Frantzoulis P; Goulis J
J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
[TBL] [Abstract][Full Text] [Related]
37. Increased production of IL-1alpha and TNF-alpha in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease.
Poniachik J; Csendes A; Díaz JC; Rojas J; Burdiles P; Maluenda F; Smok G; Rodrigo R; Videla LA
Cytokine; 2006 Mar; 33(5):252-7. PubMed ID: 16564703
[TBL] [Abstract][Full Text] [Related]
38. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2.
Haukeland JW; Damås JK; Konopski Z; Løberg EM; Haaland T; Goverud I; Torjesen PA; Birkeland K; Bjøro K; Aukrust P
J Hepatol; 2006 Jun; 44(6):1167-74. PubMed ID: 16618517
[TBL] [Abstract][Full Text] [Related]
39. Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis.
Abiru S; Migita K; Maeda Y; Daikoku M; Ito M; Ohata K; Nagaoka S; Matsumoto T; Takii Y; Kusumoto K; Nakamura M; Komori A; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
Liver Int; 2006 Feb; 26(1):39-45. PubMed ID: 16420507
[TBL] [Abstract][Full Text] [Related]
40. Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C virus infection and non-alcoholic fatty liver disease.
Vecchiet J; Falasca K; Cacciatore P; Zingariello P; Dalessandro M; Marinopiccoli M; D'Amico E; Palazzi C; Petrarca C; Conti P; Pizzigallo E; Guagnano MT
Ann Clin Lab Sci; 2005; 35(4):415-22. PubMed ID: 16254258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
